Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/3198Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sathish K. Konidala | - |
| dc.date.accessioned | 2026-04-20T12:25:59Z | - |
| dc.date.available | 2026-04-20T12:25:59Z | - |
| dc.date.issued | 2026-04-20 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/3198 | - |
| dc.description | Vol61, No. 65, p24 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | molecular docking | en_US |
| dc.subject | drugs repurposing | en_US |
| dc.title | In silico molecular docking studies of coumari-chalcone hybrids against sars-COV2 main protease (6LU7) | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol61, No. 5, 2024 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.